Subscribe: Biotechnology
http://rss.prnewswire.com/industry/bio
Added By: Feedage Forager Feedage Grade A rated
Language: English
Tags:
aarhus  bioreliance®  centro  china  company  darmstadt  merck  natera  new  prnewswire merck  prnewswire  sept prnewswire  sept 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Biotechnology

PR Newswire: Biotechnology



Press Releases from PR Newswire about Biotechnology



Published: Sat, 23 Sep 2017 00:30:45 EDT

Last Build Date: Fri, 22 Sep 2017 20:24:00 EDT

 



RepliCel Retains Hybrid Financial for Investor Relations

Fri, 22 Sep 2017 20:24:00 EDT

(image) VANCOUVER, Sept. 22, 2017 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB:REPCF) (TSXV:RP) (FRA:P6P2) ("RepliCel" or the "Company"), a company developing next-generation technologies in aesthetics and orthopedics, is pleased to announce that it has retained Hybrid Financial Inc....



Media Files:
www.replicel.com




MabVax Therapeutics Holdings, Inc. Announces $1.25 Million Registered Direct Offering

Fri, 22 Sep 2017 15:30:00 EDT

(image) SAN DIEGO, Sept. 22, 2017 /PRNewswire/ -- MabVax Therapeutics Holdings, Inc. (Nasdaq: MBVX), a clinical-stage biotechnology company focused on the development of antibody-based products to address unmet medical needs in the treatment of cancer, today announced that it has agreed to sell...



Media Files:
https://mma.prnewswire.com/media/512104/MabVax_Therapeutics_Logo.jpg




New Jersey Health Foundation Awards $50,000 Innovation Grant to Develop Biochip for Simplified, Faster Disease Detection, Diagnosis & Monitoring

Fri, 22 Sep 2017 13:20:00 EDT

(image) NEW BRUNSWICK, N.J., Sept. 22, 2017 /PRNewswire-USNewswire/ -- New Jersey Health Foundation (NJHF) has awarded a $50,000 Innovation Grant to Eon Soo Lee, assistant professor of mechanical and industrial engineering at NJIT (New Jersey Institute of Technology), to help advance the...



Media Files:
http://www.njhf.org




Lucile Packard Children's Hospital Stanford and Stanford Children's Health receive global accolades for use of health information technology

Fri, 22 Sep 2017 10:00:00 EDT

(image) CHICAGO, Sept. 22, 2017 /PRNewswire-USNewswire/ -- Stanford Children's Health and Lucile Packard Children's Hospital Stanford have been awarded the Healthcare Information and Management Systems Society (HIMSS) 2017 Enterprise Nicholas E. Davies Award of Excellence for outstanding...



Media Files:
https://mma.prnewswire.com/media/559863/Lucile_Packard_Childrens_Hospital_Standford.jpg




Life Science Instrumentation Market Worth 75.24 Billion USD by 2022

Fri, 22 Sep 2017 09:30:00 EDT

(image) PUNE, India, September 22, 2017 /PRNewswire/ -- According to a new market research report "Life Science Instrumentation Market by Technology (Spectroscopy, Chromatography, Flow Cytometry, NGS, PCR, Microscopy), Application (Research, Clinical), End User (Pharma-Biotech Companies, Food...



Media Files:
http://photos.prnewswire.com/prn/20160303/792302




Neogen announces management change

Fri, 22 Sep 2017 08:00:00 EDT

(image) LANSING, Mich., Sept. 22, 2017 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that Richard E. Calk Jr., formerly president and chief operating officer, has resigned from the company to pursue alternative opportunities. Calk's duties have been assumed by John Adent,...



Media Files:
http://www.neogen.com




China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 7, 2017

Fri, 22 Sep 2017 06:45:00 EDT

(image) HONG KONG, Sept. 22, 2017 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company will...



Media Files:
http://www.chinacordbloodcorp.com




Technical Snapshots for These Biotech Stocks -- ImmunoCellular Therapeutics, Protalix BioTherapeutics, Synthetic Biologics, and Abeona Therapeutics

Fri, 22 Sep 2017 06:35:00 EDT

NEW YORK, September 22, 2017 /PRNewswire/ -- If you want a Stock Review on IMUC, PLX, SYN, or ABEO then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. For today, DailyStockTracker.com shifts focus on the Biotech space, which harnesses...



Natera Selected for Circulating Tumor DNA Study in Bladder Cancer

Fri, 22 Sep 2017 03:20:00 EDT

(image) SAN CARLOS, Calif. and AARHUS, Denmark, Sept. 22, 2017 /PRNewswire/ -- Natera, Inc., (NASDAQ: NTRA), a global leader in cell-free DNA testing, has entered into a research collaboration with Denmark's Aarhus University to leverage the company's Signatera™ (RUO) personalized liquid biopsy...



Media Files:
https://mma.prnewswire.com/media/196532/natera_logo.jpg




Natera sélectionnée pour une étude sur l'ADN tumoral circulant dans le cadre du cancer de la vessie

Fri, 22 Sep 2017 03:20:00 EDT

(image) L'Université d'Aarhus au Danemark utilisera la technologie d'ADNtc Signatera™ dans le cadre d'une étude longitudinale SAN CARLOS, Californie et AARHUS, Danemark, le 22 septembre 2017 /PRNewswire/ -- Natera, Inc., (NASDAQ : NTRA), leader mondial en tests ADN sans cellules...



Media Files:
https://mma.prnewswire.com/media/196532/natera_logo.jpg




Natera seleccionada para un estudio del ADN tumoral circulante en el cáncer de vejiga

Fri, 22 Sep 2017 03:20:00 EDT

(image) La Universidad de Aarhus en Dinamarca utilizará la tecnología de análisis de ADN tumoral circulante Signatera™ en un estudio longitudinal SAN CARLOS, California y AARHUS, Dinamarca, 22 de septiembre de 2017 /PRNewswire/ -- Natera, Inc., (NASDAQ: NTRA), una de las empresas líderes del...



Media Files:
https://mma.prnewswire.com/media/196532/natera_logo.jpg




Natera für Studie zu Zirkulierender Tumor-DNA bei Blasenkrebs ausgewählt

Fri, 22 Sep 2017 03:20:00 EDT

(image) Dänische Universität Aarhus wird Signatera™ ctDNA-Technologie bei Längsschnittstudie einsetzen SAN CARLOS, Kalifornien, und AARHUS, Dänemark, 22. September 2017 /PRNewswire/ -- Natera, Inc., (NASDAQ: NTRA), ein weltweit führender Anbieter von zellfreien DNA-Tests, hat eine...



Media Files:
http://mma.prnewswire.com/media/196532/natera_logo.jpg




Merck otvára v Šanghaji prvé komplexné centrum pre biologický vývoj BioReliance® v Číne

Thu, 21 Sep 2017 22:00:00 EDT

(image) - Prvé komplexné centrum spoločnosti mimo Európy - Zrýchlenie klinického vývoja od molekuly ku komerčnej výrobe DARMSTADT, Nemecko, 22. septembra 2017 /PRNewswire/ -- Merck, popredná vedecká a technologická spoločnosť, dnes oznámila otvorenie prvého komplexného centra pre biologic...



Media Files:
http://mma.prnewswire.com/media/558527/Merck_BioReliance_Center_in_China.jpg




Merck abre o primeiro Centro de Biodesenvolvimento Ponta a Ponta BioReliance® da China em Xangai

Thu, 21 Sep 2017 22:00:00 EDT

(image) DARMSTADT, Alemanha, 22 de setembro de 2017 /PRNewswire/ -- A Merck, empresa líder em ciência e tecnologia, anunciou hoje a inauguração de seu primeiro Centro de Biodesenvolvimento Ponta a Ponta BioReliance®  na região da Ásia e do Pacífico (APAC). Localizado em Xangai, China, o centro irá...



Media Files:
https://mma.prnewswire.com/media/558998/Merck_BioReliance_Center_in_China.jpg




Merck inaugura el primer Centro de Biodesarrollo Integral BioReliance® de China en Shanghái

Thu, 21 Sep 2017 22:00:00 EDT

(image) DARMSTADT, Alemania, 21 de septiembre de 2017 /PRNewswire/ -- Merck, una empresa líder en los campos de la ciencia y la tecnología, anunció hoy la inauguración de su primer Centro de Biodesarrollo Integral BioReliance® en la región de Asia Pacífico. El centro, situado en Shanghái, China,...



Media Files:
https://mma.prnewswire.com/media/558999/Merck_BioReliance_Center_in_China.jpg




Merck otwiera pierwsze w Chinach centrum biorozwoju typu end-to-end BioReliance® w Szanghaju

Thu, 21 Sep 2017 22:00:00 EDT

(image) - Pierwsze tego typu centrum firmy poza granicami Europy - Przyspieszenie rozwoju klinicznego od poziomu molekuły do produkcji masowej DARMSTADT, Niemcy, 22 września 2017 r. /PRNewswire/ -- Wiodąca w zakresie nauki i rozwiązań technologicznych firma Merck ogłosiła dzisiaj...



Media Files:
http://mma.prnewswire.com/media/558527/Merck_BioReliance_Center_in_China.jpg




Společnost Merck otevřela první komplexní centrum biologického vývoje BioReliance® v Šanghaji

Thu, 21 Sep 2017 22:00:00 EDT

(image) - První komplexní centrum společnosti mimo Evropu - Urychluje klinický vývoj od molekul až po komerční výrobu DARMSTADT, Německo, 22. září 2017 /PRNewswire/ -- Přední vědeckotechnologická společnost Merck dnes oznámila otevření svého prvního komplexního centra biologického vývoje B...



Media Files:
http://mma.prnewswire.com/media/558527/Merck_BioReliance_Center_in_China.jpg




Merck abre en Shanghái el primer centro de biodesarrollo de extremo a extremo BioReliance® de China

Thu, 21 Sep 2017 22:00:00 EDT

(image) - Constituye el primer centro de extremo a extremo de la empresa fuera de Europa - Acelera el desarrollo clínico desde la fase molecular hasta la producción comercial DARMSTADT, Alemania, 22 de septiembre de 2017 /PRNewswire/ -- Merck, una de las principales empresas...



Media Files:
http://mma.prnewswire.com/media/558527/Merck_BioReliance_Center_in_China.jpg




Merck ouvre le premier centre de biodéveloppement de bout en bout BioReliance® de Chine à Shanghai

Thu, 21 Sep 2017 22:00:00 EDT

(image) - Il s'agit du premier centre de bout en bout de la société hors d'Europe - Il accélère le développement clinique, de la molécule à la production commerciale DARMSTADT, Allemagne, le 22 septembre 2017 /PRNewswire/ -- Merck, société leader dans le domaine des sciences et de la...



Media Files:
http://mma.prnewswire.com/media/558527/Merck_BioReliance_Center_in_China.jpg




Merck открывает первый центр комплексных биоразработок BioReliance® в Шанхае

Thu, 21 Sep 2017 22:00:00 EDT

(image) - Первый комплексный центр компании за пределами Европы - Новый центр ускоряет процесс клинической разработки препаратов от молекулы до коммерческого производства ДАРМШТАДТ (DARMSTADT), Германия, 22 сентября 2017 г. /PRNewswire/ -- Ведущая научно-технологическая компания Merck...



Media Files:
http://mma.prnewswire.com/media/558527/Merck_BioReliance_Center_in_China.jpg